Classification of non-small cell lung cancer based on copy number alterations

PLoS One. 2014 Feb 5;9(2):e88300. doi: 10.1371/journal.pone.0088300. eCollection 2014.

Abstract

Lung cancer is one of the leading causes of cancer mortality worldwide and non-small cell lung cancer (NSCLC) accounts for the most part. NSCLC can be further divided into adenocarcinoma (ACA) and squamous cell carcinoma (SCC). It is of great value to distinguish these two subgroups clinically. In this study, we compared the genome-wide copy number alterations (CNAs) patterns of 208 early stage ACA and 93 early stage SCC tumor samples. As a result, 266 CNA probes stood out for better discrimination of ACA and SCC. It was revealed that the genes corresponding to these 266 probes were enriched in lung cancer related pathways and enriched in the chromosome regions where CNA usually occur in lung cancer. This study sheds lights on the CNA study of NSCLC and provides some insights on the epigenetic of NSCLC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / classification
  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Carcinoma, Non-Small-Cell Lung / classification
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Squamous Cell / classification
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • DNA Copy Number Variations*
  • Gene Dosage
  • Humans
  • Lung / metabolism
  • Lung / pathology
  • Lung Neoplasms / classification
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology

Grants and funding

This work was supported by grants from National Basic Research Program of China (2011CB510101, 2011CB510102), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), and the grant of “The First-class Discipline of Universities in Shanghai”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.